WHO Publishes New Data, Finds Country Variations In Overuse, Misuse Of Antibiotics 12/11/2018 David Branigan The World Health Organization published new data today that it says “reveals wide differences in consumption of antibiotics in different countries,” suggesting overuse and misuse of these life-saving medicines, which contributes to antibiotic resistance. Continue reading -> Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Global Health Grand Challenges Meeting Ends On Hopeful Note 19/10/2018 Monika Ermert More dedicated to scientific research and much more “colourful” than the World Health Summit were descriptions for the 14th Global Grand Challenges Meeting 2018 that ended last night in Berlin and brought together some top researchers, policymakers and civil society. Like the WHS, the Grand Challenges Meeting focused on antimicrobial resistances and pandemic pathogens. But it also talked a little more on the issue of how better to incentivize R&D to fulfil SDG3, the UN Sustainable Development Goal on health, according to participants. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Industry Coalition Tries To Get Out Front Of Antibiotic Resistance Efforts 12/11/2018 William New As governments increasingly mobilise to address the now-recognised urgency of creating new antibiotics before humanity develops resistance to existing ones, the pharmaceutical industry broadly is trying to position itself to be helpful in the effort. In a statement today, an industry alliance on antimicrobial resistance reported on its progress this year to date. Continue reading -> Global Health Grand Challenges Meeting Ends On Hopeful Note 19/10/2018 Monika Ermert More dedicated to scientific research and much more “colourful” than the World Health Summit were descriptions for the 14th Global Grand Challenges Meeting 2018 that ended last night in Berlin and brought together some top researchers, policymakers and civil society. Like the WHS, the Grand Challenges Meeting focused on antimicrobial resistances and pandemic pathogens. But it also talked a little more on the issue of how better to incentivize R&D to fulfil SDG3, the UN Sustainable Development Goal on health, according to participants. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Grand Challenges Meeting Ends On Hopeful Note 19/10/2018 Monika Ermert More dedicated to scientific research and much more “colourful” than the World Health Summit were descriptions for the 14th Global Grand Challenges Meeting 2018 that ended last night in Berlin and brought together some top researchers, policymakers and civil society. Like the WHS, the Grand Challenges Meeting focused on antimicrobial resistances and pandemic pathogens. But it also talked a little more on the issue of how better to incentivize R&D to fulfil SDG3, the UN Sustainable Development Goal on health, according to participants. Continue reading -> Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 Catherine Saez The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors. Continue reading -> Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Novartis, GARDP Join Forces To Reduce Child Deaths From Antimicrobial Resistance 16/10/2018 David Branigan Novartis and the Global Antibiotic Research & Development Partnership (GARDP) have announced that they are “joining forces” to reduce child deaths from antimicrobial resistance (AMR) by accelerating “the development and availability of generic antibiotic treatments for children in low- and middle-income countries,” according to a GARDP press release. Continue reading -> Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Broad Inter-Agency Group Embarks Upon Recommendations For Global Antimicrobial Resistance Policy 03/10/2018 Tatum Anderson A global group of experts representing animal health, human health, food safety and environmental health is currently deliberating ways to control antimicrobial resistance, a nightmare scenario in which drugs able to fight the deadliest infections stop working. Continue reading -> Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Draft Global Framework On Antimicrobial Resistance In Discussion This Week At WHO 01/10/2018 Catherine Saez In an effort to curb antimicrobial resistance and the looming disaster of a defenceless world against bacterial infection, three United Nations organisations have joined forces. The World Health Organization, the Food and Agriculture Organization of the UN, and the World Organization for Animal Health have been tasked to establish a global framework which would encourage the development of new antibiotics and the good management of current ones. This week, WHO member states and stakeholders are meeting to discuss a draft of the framework. Continue reading -> New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New R&D Models And Incentives Necessary To Step Up Fight Against AMR, EU Parliament Declares 13/09/2018 Monika Ermert The European Parliament has called on the Commission to do more in the fight against antimicrobial resistance in a resolution passed on 13 September in Strasbourg with an overwhelming majority (589 in favour, 12 against, 36 abstentions). Continue reading -> Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Measles Can Be Eliminated, But Commitment Of All Countries Is Needed, Officials Say 27/08/2018 Leila Ueberschlag A record more than 41,000 children and adults in the World Health Organization European Region have been infected with measles - one of the most vaccine-preventable infectious diseases known to man – in the first 6 months of 2018, according to a newly published WHO press release. The total number for this period far exceeds the 12-month totals reported for every other year this decade, and this has policymakers grasping for ways to address the rise, while a WHO official says elimination is possible. Continue reading -> European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Medicines Agency To Be Hit Hard By Brexit Move, It Says 02/08/2018 William New The European Medicines Agency (EMA), which is oversees the scientific evaluation, supervision and safety of medicines in the European Union, will scale back activities through 2019 due to significant staff loss when it moves from London to Amsterdam in March 2019 as a result of Brexit. Some of the areas that could be affected include the agency's work at the international level on supply chain integrity, antimicrobial resistance, vaccines, and clinical data analysis. Continue reading -> Posts navigation Older postsNewer posts